Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04364503 · ClinicalTrials.gov registry record
Compliant Analysis of Patient Samples and Data
A clinical trial of Cancer and Pregnancy Related, sponsored by Sequenom.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT04364503: Recruiting study of Cancer and Pregnancy Related, sponsored by Sequenom.
NCT04364503 is a study of Cancer and Pregnancy Related that is actively recruiting participants, run by Sequenom. The registered enrollment target is 2,000 participants, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04364503, a study of Cancer and Pregnancy Related, is actively recruiting participants, sponsored by Sequenom.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
Conditions Studied
Interventions
- DEVICE Multiple interventions depending on diagnostic test being run.
Study Locations (1)
California
- Sequenom, Inc - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2018-03-17 |
| Est. Completion | 2030-08-15 |
What NCT04364503 shows while recruiting
NCT04364503 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, below the 3,488-participant average among 615 other Cancer trials with a reported enrollment target (43% lower).
The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Multiple interventions depending on diagnostic test being run. is the first listed.
NCT04364503 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04364503 about?
NCT04364503 is a clinical study titled "Compliant Analysis of Patient Samples and Data". Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
What is the current status of trial NCT04364503?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2018-03-17. Estimated completion is 2030-08-15.
What conditions does trial NCT04364503 study?
This clinical trial studies the following conditions: Cancer, Pregnancy Related, Infectious Disease.
What interventions are being tested in trial NCT04364503?
The interventions under investigation include: Multiple interventions depending on diagnostic test being run. (DEVICE).
Who is sponsoring clinical trial NCT04364503?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04364503 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04364503's enrollment target sits among peer trials
2,000 56th of 615 higher than 553 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI